Implications of BSE infection screening data for the scale of the British BSE epidemic and current European infection levels.
about
A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New GuineaThe Croonian Lecture 2004 risk: food, fact and fantasyUpdated projections of future vCJD deaths in the UKvCJD risk in the Republic of IrelandEpidemiological evidence of higher susceptibility to vCJD in the youngExtending backcalculation to analyse BSE data.Prevalence of sheep infected with classical scrapie in Great Britain: integrating multiple sources of surveillance data for 2002The role of mathematical modelling in understanding the epidemiology and control of sheep transmissible spongiform encephalopathies: a reviewEstimation of the exposure of the UK population to the bovine spongiform encephalopathy agent through dietary intake during the period 1980 to 1996.Progress in prion vaccines and immunotherapies.An overview of transmissible spongiform encephalopathies.The identification of candidate genes and SNP markers for classical bovine spongiform encephalopathy susceptibility.Current and future molecular diagnostics for prion diseases.Decontamination and CJD: the latest guidance.Detection and control of prion diseases in food animals.Immunotherapy for prion diseases: opportunities and obstacles.Risk of prion disease transmission through bovine-derived bone substitutes: a systematic review.The transmissible spongiform encephalopathies of livestock.Is there a decline in bovine spongiform encephalopathy cases born after reinforced feed bans? A modelling study in EU member states.A case cluster of variant Creutzfeldt-Jakob disease linked to the Kingdom of Saudi Arabia.Factors determining the potential for onward transmission of variant Creutzfeldt-Jakob disease via surgical instruments.Modelling the epidemic of variant Creutzfeldt-Jakob disease in the UK based on age characteristics: updated, detailed analysis.Short-term projections for variant Creutzfeldt-Jakob disease onsets.The Risk of Prion Infection through Bovine Grafting Materials.Removal of exogenous prion infectivity in leukoreduced red blood cells unit by a specific filter designed for human transfusion.TSE risk assessments: a decision support tool.Comparison of the historic recycling risk for BSE in three European countries by calculating the basic reproduction ratio R0.Expert elicitation for the judgment of prion disease risk uncertainties.Opinion of the Scientific Panel on biological hazards (BIOHAZ) on the determination of the BSE risk status of PortugalEuropean Union's rapid TSE testing in adult cattle and sheep: implementation and results in 2001 and 2002.Modelling studies on bovine spongiform encephalopathy occurrence to assist in the review of the over 30 months rule in Great Britain.Prion Disease in Dromedary Camels, Algeria.Prevalence of scrapie infection in Great Britain: interpreting the results of the 1997-1998 abattoir survey.Assessment of the risk posed by bovine spongiform encephalopathy in cattle in Great Britain and the impact of potential changes to current control measures
P2860
Q24642582-40CE592A-443F-4D56-B084-3B9D6F059A98Q24676911-4749FAA3-C813-4AE0-A427-9EFDD02737D5Q24799671-49B2602E-B8A9-40C1-B379-CB7D8D617497Q24801647-6BEFD882-33B7-496E-B41B-29E9133EF128Q24802760-6036A4CD-82F2-459B-8465-DA245841F0FDQ30807196-77C198BA-20DD-4198-B18A-C4ACA6675EE0Q31149941-92312EB0-0770-41D5-91FD-EB3F1A1BB23FQ33760128-C1996205-EBE3-43A7-A6F9-CE4926A21FE7Q35148934-8F009E1C-EEE1-4530-A39E-DBF589BBA1CDQ36040834-8BDFDDF0-FCC3-4189-A73B-2A0BC4F1B8C5Q36177322-9B4DE004-A2CC-4118-AAE6-937A50F8D8F7Q36436187-A292FA6B-0591-4FEC-9104-6A96138A7518Q36528891-3280F871-1F9D-40A4-AA90-846AF0E66787Q36670760-A629EE79-DFCD-42F6-B69C-511EBD18613FQ36857700-6B0B394F-3BA4-4326-B4E1-9A646E73E266Q37773260-EB5F8DEA-E80F-4578-94A9-D5CFE74C86B1Q37968613-90039B94-365F-4520-A403-E27CCBF5365FQ38492754-A275C23D-23C6-4313-BC60-210E149A2740Q38720699-AF71880C-B108-4E39-95D5-4F7CF2C5008FQ38817451-FB69805B-A205-4B44-97F5-27015BA6B5B8Q39018369-9BDB8C5B-3C2C-4B93-8E99-6C1B3366447AQ40578772-CBF27BD4-471B-436B-BFE1-6B6452F22442Q40578783-369E68DC-F9E6-4519-BB4D-3D04C60D2431Q40800092-2575D9C5-DF52-4795-8FEB-44E945C5A94FQ42244678-7068B1F6-E556-43DF-B76B-7D1DDDFC0E9EQ43364185-D07E4132-9C82-4F68-B03B-1BD9AADBDD23Q43798805-63A15A98-3B01-4525-8EE9-01DCD947CDFEQ44691333-96D4E5EF-6697-45E3-808D-E1A7492D3565Q47143514-0CF72F21-AF18-4EC4-8F90-0971C9581826Q47801988-0D62EABB-273D-4333-862E-37EF593EB248Q54357585-D875336A-B62D-41FC-BAE3-A60E9474701DQ55234271-7B455817-204C-4578-931F-79F360494E2FQ55364673-7F1B8CAE-C8CB-4426-B4C8-8340F692D8A9Q56830850-632059DC-93A0-4ECE-820C-61E90EC0DE6F
P2860
Implications of BSE infection screening data for the scale of the British BSE epidemic and current European infection levels.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Implications of BSE infection ...... ent European infection levels.
@en
Implications of BSE infection ...... ent European infection levels.
@nl
type
label
Implications of BSE infection ...... ent European infection levels.
@en
Implications of BSE infection ...... ent European infection levels.
@nl
prefLabel
Implications of BSE infection ...... ent European infection levels.
@en
Implications of BSE infection ...... ent European infection levels.
@nl
P2860
P50
P356
P1476
Implications of BSE infection ...... ent European infection levels.
@en
P2860
P304
P356
10.1098/RSPB.2002.2156
P577
2002-11-01T00:00:00Z